Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy InterContinental Hotels Group (IHG) by Ben McPoland in The Motley Fool
- Buy Scottish Mortgage Inv Trust (SMT) by Ben McPoland in The Motley Fool
- Watch Filtronic (FTC) by Edward Sheldon in The Motley Fool
- Buy Lloyds Banking Group (LLOY) by Shore Capital
- Buy Bunzl (BNZL) by Shore Capital
- Hold Tortilla Mexican Grill (MEX) by Shore Capital
- Buy EnQuest (ENQ) by Canaccord Genuity
- Buy Hochschild Mining (HOC) by Canaccord Genuity
- Buy Tracsis (TRCS) by Berenberg
- Buy Angle (AGL) by Berenberg
- Buy Star Energy Group (STAR) by Canaccord Genuity
- Buy Jet2 (JET2) by Canaccord Genuity
- Buy ActiveOps (AOM) by Canaccord Genuity
- Buy Ecora Resources (ECOR) by Canaccord Genuity
- Buy Reckitt Benckiser Group (RKT) by Bank of America
- Avoid Ilika (IKA) by Steve Moore in ShareProphets
- Hold Vodafone Group (VOD) by Christopher Ruane in The Motley Fool
- Outperform Reckitt Benckiser Group (RKT) by RBC Capital
- Avoid Tinybuild Inc. (DI) (TBLD) by Steve Moore in ShareProphets
- Buy City of London Inv Trust (CTY) by Alan Oscroft in The Motley Fool
Maxcyte (DI) (MXCT) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Maxcyte (DI) (MXCT)
| Latest Bid : 300.00p | Latest Ask : 310.00p |
| High Today : 336.00p | Low Today : 300.00p |
| This Years High : 420.00p | This Years Low : 210.00p |
| Volume : 12,023 | MKT Cap : £317.2M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Maxcyte (DI) (MXCT) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.Maxcyte (DI) (MXCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 24.49% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -15.28% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -27.38% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -60.13% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -72.27% |
Maxcyte (DI) (MXCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 300.00p | Latest Ask : 310.00p |
| High Today : 336.00p | Low Today : 300.00p |
| This Years High : 420.00p | This Years Low : 210.00p |
| Volume : 12,023 | MKT Cap : £317.2M |
Maxcyte (DI) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Maxcyte (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | 24.49% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -15.28% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -27.38% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -60.13% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -72.27% |